About NCS Diagnostics Private Limited
Data last updated:
NCS Diagnostics Private Limited is a private limited company based in Kolkata, West Bengal, India. It operates in the diagnostic centers and pathology labs segment of the healthcare sector. It was incorporated on 26 November 1997 and has been in existence for over 29 years.
The company is registered with the Registrar of Companies (ROC), Kolkata, under CIN U24231WB1997PTC085984.
The company has an authorised share capital of ₹60 Lakh and a paid-up capital of ₹48.46 Lakh. It was formerly known as Eastersn Fertility & Genetic Research Center Private Limited. It is led by directors Kamal Chand Oswal and Poonam Rathore.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at P – 41 Kshirode Vidya Vinode Avenue Baghbazar, Kolkata, West Bengal, India – 700003.
As per the financials filed for FY 2024, the company reported a revenue of ₹5.12 Cr, a growth of 24% compared to the previous year. For the same year it recorded a net profit of ₹38.09 Lakh (net margin 7.4%) and EBITDA of ₹1.27 Cr (EBITDA margin 24.8%). Revenue has grown at a compounded annual rate (CAGR) of 22% over three years and 8% over five years.
The company has about 22 employees on its provident fund (EPFO) records.
As per MCA filings, the company has open charges of ₹9.95 Cr and satisfied charges of ₹3.53 Cr on record.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website ncs-diagnostic.business.site.
- EmailLocked
- TelephoneLocked
- Website
- Social MediaLocked
- Registered AddressP – 41 Kshirode Vidya Vinode Avenue Baghbazar, Kolkata, West Bengal, India – 700003
- IndustryHealthcare, Diagnostic Centers & Pathology Labs
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of NCS Diagnostics Private Limited
The main business activity of NCS Diagnostics is hospital and medical care. In detail, this covers medical and dental practice, nursing, pathology, blood bank services, etc..
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| Q | Hospital and Medical Care | Q2 | Medical and dental practice, Nursing, pathology, blood bank services, etc. | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Auditor Details of NCS Diagnostics Private Limited
NCS Diagnostics Private Limited is audited by D. K. PARMANANDKA & CO. for the financial year 2022.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| D. K. PARMANANDKA & CO. | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of NCS Diagnostics Private Limited
NCS Diagnostics has 2 current directors and 4 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Kamal Chand Oswal | Director | 04 Jan 1999 | 27 Years 9 Months | Current |
| Poonam Rathore | Director | 08 Apr 2023 | 3 Years 5 Months | Current |
Financials of NCS Diagnostics Private Limited FY 2024 filings available
NCS Diagnostics Private Limited reported revenue of ₹5.12 Cr (up 24% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR) of NCS Diagnostics Private Limited
Revenue has grown at a compounded annual rate (CAGR) of 8% over five years, including 24% growth in the latest year. EBITDA rose 22% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of NCS Diagnostics Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹1.27 Cr | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹38.09 Lakh | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of NCS Diagnostics Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 24.8% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 7.4% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of NCS Diagnostics are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Ownership and Shareholding of NCS Diagnostics Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of NCS Diagnostics Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 29 Jul 2025 | Hdfc Bank Limited | ₹31 Lakh | Open |
| 26 Sep 2024 | Hdfc Bank Limited | ₹1.52 Cr | Open |
| 21 Aug 2024 | Hdfc Bank Limited | ₹8.6 Lakh | Open |
| 27 Mar 2024 | Hdfc Bank Limited | ₹1.33 Cr | Open |
| 08 Jan 2024 | Hdfc Bank Limited | ₹27 Lakh | Open |
Total charge records: 21 View all charges
Employees and EPFO Compliance at NCS Diagnostics Private Limited
NCS Diagnostics Private Limited has a workforce of 22 employees as of Apr 07, 2024.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
GST Compliance of NCS Diagnostics Private Limited
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
Credit Ratings, Litigation & Regulatory Alerts for NCS Diagnostics Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by NCS Diagnostics Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of NCS Diagnostics Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
MCA Filings & Documents of NCS Diagnostics Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Recent Activity on NCS Diagnostics Private Limited
Frequently Asked Questions about NCS Diagnostics Private Limited
NCS Diagnostics is an active private limited company based in Kolkata, West Bengal, India. The company works in diagnostic centers and pathology labs, within the healthcare industry. It was incorporated on 26 November 1997 (29+ years old) and is registered under CIN U24231WB1997PTC085984.
NCS Diagnostics reported revenue of ₹5.12 Cr for FY 2024 (up 24% YoY).
NCS Diagnostics has 2 current directors:
- Kamal Chand Oswal - Director
- Poonam Rathore - Director
NCS Diagnostics reported a net profit of ₹38.09 Lakh (net margin 7.4%) and EBITDA of ₹1.27 Cr (EBITDA margin 24.8%) for FY 2024, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of NCS Diagnostics is 22% over three years and 8% over five years. In the latest year (FY 2024) revenue rose 24%. CAGR is the steady yearly rate that links the first and the last year.
The CIN (Corporate Identification Number) of NCS Diagnostics is U24231WB1997PTC085984. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
NCS Diagnostics was incorporated on 26 November 1997, making it 29+ years old. It is registered with the Registrar of Companies, Kolkata.
NCS Diagnostics can be reached through the website ncs-diagnostic.business.site. Its registered office is in Kolkata, West Bengal, India.
The registered office of NCS Diagnostics is at P – 41 Kshirode Vidya Vinode Avenue Baghbazar, Kolkata, West Bengal, India – 700003.